Understanding how cells manage protein breakdown
Defining the Function of Proteasomal Deubiquitinases
This research explores how cells break down proteins, a process that goes wrong in many cancers and brain conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Massachusetts Amherst NIH-funded |
| Lab location | 1 site (Hadley, United States) |
| Project ID | NIH-11121846 on NIH RePORTER |
What this research studies
Our cells have a recycling system, called the 26S proteasome, that breaks down old or damaged proteins. This project focuses on special enzymes called deubiquitinases, which help control this essential breakdown process. When protein breakdown doesn't work correctly, it can contribute to serious health issues like cancer and neurological diseases. Researchers will use advanced laboratory techniques to study a specific deubiquitinase, UCH37, which is linked to poor outcomes in some cancers. The goal is to learn exactly how UCH37 works and to create new tools that could lead to future drug development.
Who could benefit from this research
Good fit: Patients with certain cancers and neurological disorders, where protein breakdown is not working correctly, could potentially benefit from future treatments developed from this basic understanding.
Not a fit: Patients whose conditions are not related to the misregulation of protein degradation by the 26S proteasome would likely not receive direct benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new drug targets for treating cancers and neurological disorders by correcting faulty protein breakdown.
How similar studies have performed: While the general role of protein degradation in disease is known, this specific approach to understanding UCH37's function and developing interfering tools is a novel area of exploration.
Where this research is happening
Hadley, United States
- University of Massachusetts Amherst — Hadley, United States (Active)
Researchers
- Principal investigator: Strieter, Eric Robert — University of Massachusetts Amherst
- Study coordinator: Strieter, Eric Robert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.